Showing results (561-570 of 688) with videos related to

Sort By:
Pageof 69
RMD Open|July 16, 2020
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II studyPhilip J Mease, Dafna D Gladman, Atul Deodhar, et al.
Annals of the Rheumatic Diseases|September 30, 2019
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trialPhilip J Mease, Josef S Smolen, Frank Behrens, et al.
Arthritis Care & Research|July 18, 2013
Golimumab, a human anti–tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function findings of a phase III, multicenter, randomized, double-blind, placebo-controlled studyPaul Emery, Roy M Fleischmann, Mittie K Doyle, et al.
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis and Rheumatism|June 3, 2008
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysisOliver Distler, Frank Behrens, David Pittrow, et al.
Arthritis and Rheumatism|June 3, 2008
Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexateRachelle Buchbinder, Melissa Barber, Louise Heuzenroeder, et al.
Journal of Synchrotron Radiation|July 30, 2024
New opportunities for time-resolved imaging using diffraction-limited storage ringsZisheng Yao, Julia Rogalinski, Eleni Myrto Asimakopoulou, et al.
Scientific Reports|February 14, 2019
Analysis of SMALP co-extracted phospholipids shows distinct membrane environments for three classes of bacterial membrane proteinAlvin C K Teo, Sarah C Lee, Naomi L Pollock, et al.
The Journal of Rheumatology|January 17, 2015
Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritisArthur Kavanaugh, Philip J Mease, Juan J Gomez-Reino, et al.
Pageof 69